CLINICAL_TRIALS
research
· 2026-01-22
Clinical Trial Update: Endoscopic Gastric Mucosal Ablation as a Primary Obesity Therapy [NA]
Summary
Update on a clinical trial evaluating endoscopic gastric mucosal ablation as a primary therapy for obesity; the study is sponsored by Erbe Elektromedizin GmbH a…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Erbe Elektromedizin GmbH | Conditions: Obesity, Adiposity | NA | Status: ACTIVE_NOT_RECRUITING